NCT06381401View on ClinicalTrials.gov

Bupivacaine 0.125% Versus Bupivacaine 0.25% in Superficial Cervical Plexus Block for Tympanomastoid Surgeries in Adults

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 28, 2024

Study Completion Date

July 5, 2024

Conditions
Surgical FieldAcute Postoperative Pain
Interventions
DRUG

bupivacaine 0.25%

superficial cervical plexus block using 10 ml of bupivacaine 0.25%

DRUG

bupivacaine 0.125%

superficial cervical plexus block using 10 ml of bupivacaine 0.125%

Trial Locations (1)

Unknown

RECRUITING

Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER